nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Abdominal pain—Vinblastine—breast cancer	0.00081	0.00116	CcSEcCtD
Fenoldopam—Haemorrhage—Paclitaxel—breast cancer	0.000806	0.00116	CcSEcCtD
Fenoldopam—Angina pectoris—Capecitabine—breast cancer	0.000805	0.00116	CcSEcCtD
Fenoldopam—Blood urea increased—Doxorubicin—breast cancer	0.000802	0.00115	CcSEcCtD
Fenoldopam—Hypotension—Vinorelbine—breast cancer	0.000796	0.00114	CcSEcCtD
Fenoldopam—Tachycardia—Thiotepa—breast cancer	0.000794	0.00114	CcSEcCtD
Fenoldopam—Abdominal pain—Tamoxifen—breast cancer	0.000787	0.00113	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Goserelin—breast cancer	0.000778	0.00112	CcSEcCtD
Fenoldopam—Diarrhoea—Chlorambucil—breast cancer	0.000765	0.0011	CcSEcCtD
Fenoldopam—Dyspnoea—Vinorelbine—breast cancer	0.000759	0.00109	CcSEcCtD
Fenoldopam—Body temperature increased—Goserelin—breast cancer	0.000752	0.00108	CcSEcCtD
Fenoldopam—Abdominal pain—Goserelin—breast cancer	0.000752	0.00108	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Docetaxel—breast cancer	0.000751	0.00108	CcSEcCtD
Fenoldopam—Flushing—Paclitaxel—breast cancer	0.000748	0.00107	CcSEcCtD
Fenoldopam—Myocardial infarction—Docetaxel—breast cancer	0.000746	0.00107	CcSEcCtD
Fenoldopam—Chest pain—Mitoxantrone—breast cancer	0.000733	0.00105	CcSEcCtD
Fenoldopam—Anxiety—Mitoxantrone—breast cancer	0.00073	0.00105	CcSEcCtD
Fenoldopam—Constipation—Vinorelbine—breast cancer	0.000728	0.00104	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Capecitabine—breast cancer	0.000727	0.00104	CcSEcCtD
Fenoldopam—Myocardial infarction—Capecitabine—breast cancer	0.000723	0.00104	CcSEcCtD
Fenoldopam—Urinary tract infection—Capecitabine—breast cancer	0.000717	0.00103	CcSEcCtD
Fenoldopam—Chest pain—Gemcitabine—breast cancer	0.000714	0.00102	CcSEcCtD
Fenoldopam—Vomiting—Chlorambucil—breast cancer	0.000711	0.00102	CcSEcCtD
Fenoldopam—Chest pain—Fluorouracil—breast cancer	0.000702	0.00101	CcSEcCtD
Fenoldopam—Diarrhoea—Vinblastine—breast cancer	0.000701	0.00101	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Vinorelbine—breast cancer	0.000697	0.000999	CcSEcCtD
Fenoldopam—Constipation—Thiotepa—breast cancer	0.000696	0.000998	CcSEcCtD
Fenoldopam—Tension—Paclitaxel—breast cancer	0.000689	0.000988	CcSEcCtD
Fenoldopam—Haemoglobin—Docetaxel—breast cancer	0.000687	0.000986	CcSEcCtD
Fenoldopam—Tachycardia—Mitoxantrone—breast cancer	0.000686	0.000984	CcSEcCtD
Fenoldopam—Haemorrhage—Docetaxel—breast cancer	0.000684	0.000981	CcSEcCtD
Fenoldopam—Cardiac failure—Epirubicin—breast cancer	0.000683	0.00098	CcSEcCtD
Fenoldopam—Nervousness—Paclitaxel—breast cancer	0.000682	0.000978	CcSEcCtD
Fenoldopam—Diarrhoea—Tamoxifen—breast cancer	0.000681	0.000977	CcSEcCtD
Fenoldopam—Hyperhidrosis—Irinotecan—breast cancer	0.000679	0.000974	CcSEcCtD
Fenoldopam—Hyperhidrosis—Mitoxantrone—breast cancer	0.000679	0.000974	CcSEcCtD
Fenoldopam—Back pain—Paclitaxel—breast cancer	0.000679	0.000974	CcSEcCtD
Fenoldopam—Dizziness—Vinblastine—breast cancer	0.000678	0.000972	CcSEcCtD
Fenoldopam—Muscle spasms—Paclitaxel—breast cancer	0.000675	0.000968	CcSEcCtD
Fenoldopam—Bradycardia—Capecitabine—breast cancer	0.000674	0.000966	CcSEcCtD
Fenoldopam—Abdominal pain—Vinorelbine—breast cancer	0.000673	0.000966	CcSEcCtD
Fenoldopam—Body temperature increased—Vinorelbine—breast cancer	0.000673	0.000966	CcSEcCtD
Fenoldopam—Diarrhoea—Melphalan—breast cancer	0.000667	0.000957	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Thiotepa—breast cancer	0.000665	0.000954	CcSEcCtD
Fenoldopam—Haemoglobin—Capecitabine—breast cancer	0.000665	0.000954	CcSEcCtD
Fenoldopam—Nausea—Chlorambucil—breast cancer	0.000664	0.000953	CcSEcCtD
Fenoldopam—Haemorrhage—Capecitabine—breast cancer	0.000662	0.000949	CcSEcCtD
Fenoldopam—Hyperhidrosis—Gemcitabine—breast cancer	0.000662	0.000949	CcSEcCtD
Fenoldopam—Dizziness—Tamoxifen—breast cancer	0.000658	0.000945	CcSEcCtD
Fenoldopam—Tachycardia—Fluorouracil—breast cancer	0.000657	0.000942	CcSEcCtD
Fenoldopam—Hypotension—Irinotecan—breast cancer	0.000656	0.000942	CcSEcCtD
Fenoldopam—Hypotension—Mitoxantrone—breast cancer	0.000656	0.000942	CcSEcCtD
Fenoldopam—Vomiting—Vinblastine—breast cancer	0.000652	0.000935	CcSEcCtD
Fenoldopam—Diarrhoea—Goserelin—breast cancer	0.000651	0.000933	CcSEcCtD
Fenoldopam—Body temperature increased—Thiotepa—breast cancer	0.000643	0.000922	CcSEcCtD
Fenoldopam—Abdominal pain—Thiotepa—breast cancer	0.000643	0.000922	CcSEcCtD
Fenoldopam—Headache—Vinblastine—breast cancer	0.000642	0.000921	CcSEcCtD
Fenoldopam—Hypotension—Gemcitabine—breast cancer	0.000639	0.000917	CcSEcCtD
Fenoldopam—Insomnia—Irinotecan—breast cancer	0.000635	0.000911	CcSEcCtD
Fenoldopam—Flushing—Docetaxel—breast cancer	0.000634	0.00091	CcSEcCtD
Fenoldopam—Vomiting—Tamoxifen—breast cancer	0.000633	0.000908	CcSEcCtD
Fenoldopam—Cardiac failure—Doxorubicin—breast cancer	0.000632	0.000906	CcSEcCtD
Fenoldopam—Dizziness—Goserelin—breast cancer	0.000629	0.000902	CcSEcCtD
Fenoldopam—Hypotension—Fluorouracil—breast cancer	0.000629	0.000902	CcSEcCtD
Fenoldopam—Dyspnoea—Irinotecan—breast cancer	0.000626	0.000898	CcSEcCtD
Fenoldopam—Dyspnoea—Mitoxantrone—breast cancer	0.000626	0.000898	CcSEcCtD
Fenoldopam—Blood creatinine increased—Epirubicin—breast cancer	0.000624	0.000896	CcSEcCtD
Fenoldopam—Headache—Tamoxifen—breast cancer	0.000624	0.000895	CcSEcCtD
Fenoldopam—Palpitations—Paclitaxel—breast cancer	0.00062	0.00089	CcSEcCtD
Fenoldopam—Vomiting—Melphalan—breast cancer	0.00062	0.000889	CcSEcCtD
Fenoldopam—Insomnia—Gemcitabine—breast cancer	0.000619	0.000888	CcSEcCtD
Fenoldopam—Flushing—Capecitabine—breast cancer	0.000614	0.000881	CcSEcCtD
Fenoldopam—Dyspnoea—Gemcitabine—breast cancer	0.00061	0.000875	CcSEcCtD
Fenoldopam—Nausea—Vinblastine—breast cancer	0.000609	0.000873	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Epirubicin—breast cancer	0.000609	0.000873	CcSEcCtD
Fenoldopam—Insomnia—Fluorouracil—breast cancer	0.000609	0.000873	CcSEcCtD
Fenoldopam—Hypokalaemia—Epirubicin—breast cancer	0.000607	0.00087	CcSEcCtD
Fenoldopam—Vomiting—Goserelin—breast cancer	0.000605	0.000867	CcSEcCtD
Fenoldopam—Constipation—Mitoxantrone—breast cancer	0.000601	0.000862	CcSEcCtD
Fenoldopam—Constipation—Irinotecan—breast cancer	0.000601	0.000862	CcSEcCtD
Fenoldopam—Dyspnoea—Fluorouracil—breast cancer	0.0006	0.00086	CcSEcCtD
Fenoldopam—Chest pain—Paclitaxel—breast cancer	0.000598	0.000857	CcSEcCtD
Fenoldopam—Headache—Goserelin—breast cancer	0.000596	0.000855	CcSEcCtD
Fenoldopam—Anxiety—Paclitaxel—breast cancer	0.000596	0.000854	CcSEcCtD
Fenoldopam—Nausea—Tamoxifen—breast cancer	0.000591	0.000848	CcSEcCtD
Fenoldopam—Constipation—Gemcitabine—breast cancer	0.000585	0.000839	CcSEcCtD
Fenoldopam—Diarrhoea—Vinorelbine—breast cancer	0.000583	0.000836	CcSEcCtD
Fenoldopam—Nausea—Melphalan—breast cancer	0.000579	0.000831	CcSEcCtD
Fenoldopam—Blood creatinine increased—Doxorubicin—breast cancer	0.000578	0.000829	CcSEcCtD
Fenoldopam—Back pain—Docetaxel—breast cancer	0.000576	0.000826	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Irinotecan—breast cancer	0.000574	0.000824	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000574	0.000824	CcSEcCtD
Fenoldopam—Muscle spasms—Docetaxel—breast cancer	0.000572	0.000821	CcSEcCtD
Fenoldopam—Nausea—Goserelin—breast cancer	0.000565	0.00081	CcSEcCtD
Fenoldopam—Dizziness—Vinorelbine—breast cancer	0.000563	0.000808	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Doxorubicin—breast cancer	0.000563	0.000808	CcSEcCtD
Fenoldopam—Hypokalaemia—Doxorubicin—breast cancer	0.000561	0.000805	CcSEcCtD
Fenoldopam—Angina pectoris—Epirubicin—breast cancer	0.000561	0.000805	CcSEcCtD
Fenoldopam—Tachycardia—Paclitaxel—breast cancer	0.000559	0.000802	CcSEcCtD
Fenoldopam—Back pain—Capecitabine—breast cancer	0.000557	0.000799	CcSEcCtD
Fenoldopam—Diarrhoea—Thiotepa—breast cancer	0.000557	0.000798	CcSEcCtD
Fenoldopam—Body temperature increased—Mitoxantrone—breast cancer	0.000555	0.000797	CcSEcCtD
Fenoldopam—Body temperature increased—Irinotecan—breast cancer	0.000555	0.000797	CcSEcCtD
Fenoldopam—Abdominal pain—Mitoxantrone—breast cancer	0.000555	0.000797	CcSEcCtD
Fenoldopam—Abdominal pain—Irinotecan—breast cancer	0.000555	0.000797	CcSEcCtD
Fenoldopam—Muscle spasms—Capecitabine—breast cancer	0.000554	0.000795	CcSEcCtD
Fenoldopam—Hyperhidrosis—Paclitaxel—breast cancer	0.000554	0.000795	CcSEcCtD
Fenoldopam—Vomiting—Vinorelbine—breast cancer	0.000542	0.000777	CcSEcCtD
Fenoldopam—Body temperature increased—Gemcitabine—breast cancer	0.000541	0.000776	CcSEcCtD
Fenoldopam—Dizziness—Thiotepa—breast cancer	0.000538	0.000772	CcSEcCtD
Fenoldopam—Hypotension—Paclitaxel—breast cancer	0.000535	0.000768	CcSEcCtD
Fenoldopam—Headache—Vinorelbine—breast cancer	0.000534	0.000765	CcSEcCtD
Fenoldopam—Body temperature increased—Fluorouracil—breast cancer	0.000532	0.000763	CcSEcCtD
Fenoldopam—Sweating—Methotrexate—breast cancer	0.000526	0.000755	CcSEcCtD
Fenoldopam—Palpitations—Docetaxel—breast cancer	0.000526	0.000754	CcSEcCtD
Fenoldopam—Angina pectoris—Doxorubicin—breast cancer	0.000519	0.000745	CcSEcCtD
Fenoldopam—Insomnia—Paclitaxel—breast cancer	0.000518	0.000743	CcSEcCtD
Fenoldopam—Vomiting—Thiotepa—breast cancer	0.000517	0.000742	CcSEcCtD
Fenoldopam—Dyspnoea—Paclitaxel—breast cancer	0.000511	0.000733	CcSEcCtD
Fenoldopam—Headache—Thiotepa—breast cancer	0.00051	0.000731	CcSEcCtD
Fenoldopam—Palpitations—Capecitabine—breast cancer	0.000509	0.00073	CcSEcCtD
Fenoldopam—Chest pain—Docetaxel—breast cancer	0.000507	0.000727	CcSEcCtD
Fenoldopam—Nausea—Vinorelbine—breast cancer	0.000506	0.000726	CcSEcCtD
Fenoldopam—Urinary tract infection—Epirubicin—breast cancer	0.000499	0.000716	CcSEcCtD
Fenoldopam—Haemoglobin—Methotrexate—breast cancer	0.000495	0.00071	CcSEcCtD
Fenoldopam—Haemorrhage—Methotrexate—breast cancer	0.000493	0.000707	CcSEcCtD
Fenoldopam—Sweating—Epirubicin—breast cancer	0.000492	0.000706	CcSEcCtD
Fenoldopam—Chest pain—Capecitabine—breast cancer	0.00049	0.000704	CcSEcCtD
Fenoldopam—Constipation—Paclitaxel—breast cancer	0.00049	0.000703	CcSEcCtD
Fenoldopam—Anxiety—Capecitabine—breast cancer	0.000489	0.000701	CcSEcCtD
Fenoldopam—Nausea—Thiotepa—breast cancer	0.000483	0.000693	CcSEcCtD
Fenoldopam—Diarrhoea—Irinotecan—breast cancer	0.000481	0.000689	CcSEcCtD
Fenoldopam—Diarrhoea—Mitoxantrone—breast cancer	0.000481	0.000689	CcSEcCtD
Fenoldopam—Tachycardia—Docetaxel—breast cancer	0.000474	0.00068	CcSEcCtD
Fenoldopam—Bradycardia—Epirubicin—breast cancer	0.000469	0.000673	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Paclitaxel—breast cancer	0.000469	0.000672	CcSEcCtD
Fenoldopam—Diarrhoea—Gemcitabine—breast cancer	0.000468	0.000672	CcSEcCtD
Fenoldopam—ADRA1D—epithelium—breast cancer	0.000467	0.068	CbGeAlD
Fenoldopam—Dizziness—Irinotecan—breast cancer	0.000465	0.000666	CcSEcCtD
Fenoldopam—Haemoglobin—Epirubicin—breast cancer	0.000463	0.000665	CcSEcCtD
Fenoldopam—Urinary tract infection—Doxorubicin—breast cancer	0.000462	0.000663	CcSEcCtD
Fenoldopam—Haemorrhage—Epirubicin—breast cancer	0.000461	0.000661	CcSEcCtD
Fenoldopam—Diarrhoea—Fluorouracil—breast cancer	0.00046	0.00066	CcSEcCtD
Fenoldopam—Tachycardia—Capecitabine—breast cancer	0.000459	0.000658	CcSEcCtD
Fenoldopam—Sweating—Doxorubicin—breast cancer	0.000456	0.000654	CcSEcCtD
Fenoldopam—Hyperhidrosis—Capecitabine—breast cancer	0.000455	0.000652	CcSEcCtD
Fenoldopam—Hypotension—Docetaxel—breast cancer	0.000454	0.000651	CcSEcCtD
Fenoldopam—Abdominal pain—Paclitaxel—breast cancer	0.000453	0.00065	CcSEcCtD
Fenoldopam—Body temperature increased—Paclitaxel—breast cancer	0.000453	0.00065	CcSEcCtD
Fenoldopam—Vomiting—Mitoxantrone—breast cancer	0.000447	0.000641	CcSEcCtD
Fenoldopam—Vomiting—Irinotecan—breast cancer	0.000447	0.000641	CcSEcCtD
Fenoldopam—Dizziness—Fluorouracil—breast cancer	0.000445	0.000638	CcSEcCtD
Fenoldopam—Headache—Irinotecan—breast cancer	0.00044	0.000631	CcSEcCtD
Fenoldopam—Headache—Mitoxantrone—breast cancer	0.00044	0.000631	CcSEcCtD
Fenoldopam—Hypotension—Capecitabine—breast cancer	0.000439	0.00063	CcSEcCtD
Fenoldopam—Insomnia—Docetaxel—breast cancer	0.000439	0.00063	CcSEcCtD
Fenoldopam—Vomiting—Gemcitabine—breast cancer	0.000435	0.000624	CcSEcCtD
Fenoldopam—Bradycardia—Doxorubicin—breast cancer	0.000434	0.000623	CcSEcCtD
Fenoldopam—Dyspnoea—Docetaxel—breast cancer	0.000433	0.000621	CcSEcCtD
Fenoldopam—DRD5—female reproductive system—breast cancer	0.000432	0.063	CbGeAlD
Fenoldopam—Haemoglobin—Doxorubicin—breast cancer	0.000429	0.000615	CcSEcCtD
Fenoldopam—Headache—Gemcitabine—breast cancer	0.000429	0.000615	CcSEcCtD
Fenoldopam—Flushing—Epirubicin—breast cancer	0.000428	0.000614	CcSEcCtD
Fenoldopam—Vomiting—Fluorouracil—breast cancer	0.000428	0.000614	CcSEcCtD
Fenoldopam—Haemorrhage—Doxorubicin—breast cancer	0.000427	0.000612	CcSEcCtD
Fenoldopam—Insomnia—Capecitabine—breast cancer	0.000425	0.00061	CcSEcCtD
Fenoldopam—Headache—Fluorouracil—breast cancer	0.000422	0.000605	CcSEcCtD
Fenoldopam—Dyspnoea—Capecitabine—breast cancer	0.000419	0.000601	CcSEcCtD
Fenoldopam—Nausea—Mitoxantrone—breast cancer	0.000417	0.000599	CcSEcCtD
Fenoldopam—Nausea—Irinotecan—breast cancer	0.000417	0.000599	CcSEcCtD
Fenoldopam—Constipation—Docetaxel—breast cancer	0.000415	0.000596	CcSEcCtD
Fenoldopam—Back pain—Methotrexate—breast cancer	0.000415	0.000595	CcSEcCtD
Fenoldopam—Nausea—Gemcitabine—breast cancer	0.000406	0.000583	CcSEcCtD
Fenoldopam—Constipation—Capecitabine—breast cancer	0.000402	0.000577	CcSEcCtD
Fenoldopam—Nausea—Fluorouracil—breast cancer	0.0004	0.000573	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Docetaxel—breast cancer	0.000397	0.00057	CcSEcCtD
Fenoldopam—Flushing—Doxorubicin—breast cancer	0.000396	0.000568	CcSEcCtD
Fenoldopam—Tension—Epirubicin—breast cancer	0.000394	0.000565	CcSEcCtD
Fenoldopam—DRD5—female gonad—breast cancer	0.000393	0.0573	CbGeAlD
Fenoldopam—Diarrhoea—Paclitaxel—breast cancer	0.000392	0.000562	CcSEcCtD
Fenoldopam—Nervousness—Epirubicin—breast cancer	0.00039	0.000559	CcSEcCtD
Fenoldopam—Back pain—Epirubicin—breast cancer	0.000388	0.000557	CcSEcCtD
Fenoldopam—Muscle spasms—Epirubicin—breast cancer	0.000386	0.000554	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Capecitabine—breast cancer	0.000384	0.000552	CcSEcCtD
Fenoldopam—Abdominal pain—Docetaxel—breast cancer	0.000384	0.000551	CcSEcCtD
Fenoldopam—Body temperature increased—Docetaxel—breast cancer	0.000384	0.000551	CcSEcCtD
Fenoldopam—ADRA2C—nipple—breast cancer	0.000379	0.0553	CbGeAlD
Fenoldopam—Dizziness—Paclitaxel—breast cancer	0.000379	0.000543	CcSEcCtD
Fenoldopam—Body temperature increased—Capecitabine—breast cancer	0.000372	0.000533	CcSEcCtD
Fenoldopam—Abdominal pain—Capecitabine—breast cancer	0.000372	0.000533	CcSEcCtD
Fenoldopam—DRD5—endocrine gland—breast cancer	0.000366	0.0533	CbGeAlD
Fenoldopam—Chest pain—Methotrexate—breast cancer	0.000365	0.000524	CcSEcCtD
Fenoldopam—Tension—Doxorubicin—breast cancer	0.000364	0.000523	CcSEcCtD
Fenoldopam—Vomiting—Paclitaxel—breast cancer	0.000364	0.000523	CcSEcCtD
Fenoldopam—Nervousness—Doxorubicin—breast cancer	0.000361	0.000517	CcSEcCtD
Fenoldopam—Back pain—Doxorubicin—breast cancer	0.000359	0.000515	CcSEcCtD
Fenoldopam—Headache—Paclitaxel—breast cancer	0.000359	0.000515	CcSEcCtD
Fenoldopam—Muscle spasms—Doxorubicin—breast cancer	0.000357	0.000512	CcSEcCtD
Fenoldopam—Palpitations—Epirubicin—breast cancer	0.000355	0.000509	CcSEcCtD
Fenoldopam—ADRA1D—female reproductive system—breast cancer	0.000347	0.0505	CbGeAlD
Fenoldopam—Chest pain—Epirubicin—breast cancer	0.000342	0.00049	CcSEcCtD
Fenoldopam—Anxiety—Epirubicin—breast cancer	0.000341	0.000488	CcSEcCtD
Fenoldopam—Nausea—Paclitaxel—breast cancer	0.00034	0.000488	CcSEcCtD
Fenoldopam—Hyperhidrosis—Methotrexate—breast cancer	0.000338	0.000485	CcSEcCtD
Fenoldopam—Diarrhoea—Docetaxel—breast cancer	0.000332	0.000477	CcSEcCtD
Fenoldopam—Palpitations—Doxorubicin—breast cancer	0.000328	0.000471	CcSEcCtD
Fenoldopam—Hypotension—Methotrexate—breast cancer	0.000327	0.000469	CcSEcCtD
Fenoldopam—Diarrhoea—Capecitabine—breast cancer	0.000322	0.000461	CcSEcCtD
Fenoldopam—Dizziness—Docetaxel—breast cancer	0.000321	0.000461	CcSEcCtD
Fenoldopam—Tachycardia—Epirubicin—breast cancer	0.00032	0.000459	CcSEcCtD
Fenoldopam—Hyperhidrosis—Epirubicin—breast cancer	0.000317	0.000454	CcSEcCtD
Fenoldopam—Insomnia—Methotrexate—breast cancer	0.000317	0.000454	CcSEcCtD
Fenoldopam—Chest pain—Doxorubicin—breast cancer	0.000316	0.000454	CcSEcCtD
Fenoldopam—Anxiety—Doxorubicin—breast cancer	0.000315	0.000452	CcSEcCtD
Fenoldopam—Dyspnoea—Methotrexate—breast cancer	0.000312	0.000448	CcSEcCtD
Fenoldopam—Dizziness—Capecitabine—breast cancer	0.000311	0.000446	CcSEcCtD
Fenoldopam—Vomiting—Docetaxel—breast cancer	0.000309	0.000443	CcSEcCtD
Fenoldopam—Hypotension—Epirubicin—breast cancer	0.000306	0.000439	CcSEcCtD
Fenoldopam—Headache—Docetaxel—breast cancer	0.000304	0.000436	CcSEcCtD
Fenoldopam—ADRA2A—nipple—breast cancer	0.000303	0.0441	CbGeAlD
Fenoldopam—Vomiting—Capecitabine—breast cancer	0.000299	0.000429	CcSEcCtD
Fenoldopam—Insomnia—Epirubicin—breast cancer	0.000296	0.000425	CcSEcCtD
Fenoldopam—Tachycardia—Doxorubicin—breast cancer	0.000296	0.000424	CcSEcCtD
Fenoldopam—Headache—Capecitabine—breast cancer	0.000295	0.000423	CcSEcCtD
Fenoldopam—ADRA1D—endocrine gland—breast cancer	0.000293	0.0427	CbGeAlD
Fenoldopam—Hyperhidrosis—Doxorubicin—breast cancer	0.000293	0.00042	CcSEcCtD
Fenoldopam—Dyspnoea—Epirubicin—breast cancer	0.000292	0.000419	CcSEcCtD
Fenoldopam—Nausea—Docetaxel—breast cancer	0.000288	0.000414	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Methotrexate—breast cancer	0.000286	0.000411	CcSEcCtD
Fenoldopam—Hypotension—Doxorubicin—breast cancer	0.000283	0.000406	CcSEcCtD
Fenoldopam—Constipation—Epirubicin—breast cancer	0.00028	0.000402	CcSEcCtD
Fenoldopam—Nausea—Capecitabine—breast cancer	0.000279	0.000401	CcSEcCtD
Fenoldopam—Abdominal pain—Methotrexate—breast cancer	0.000277	0.000397	CcSEcCtD
Fenoldopam—Body temperature increased—Methotrexate—breast cancer	0.000277	0.000397	CcSEcCtD
Fenoldopam—Insomnia—Doxorubicin—breast cancer	0.000274	0.000393	CcSEcCtD
Fenoldopam—Dyspnoea—Doxorubicin—breast cancer	0.00027	0.000388	CcSEcCtD
Fenoldopam—ADRA1A—epithelium—breast cancer	0.000268	0.0391	CbGeAlD
Fenoldopam—Gastrointestinal pain—Epirubicin—breast cancer	0.000268	0.000384	CcSEcCtD
Fenoldopam—Constipation—Doxorubicin—breast cancer	0.000259	0.000372	CcSEcCtD
Fenoldopam—Body temperature increased—Epirubicin—breast cancer	0.000259	0.000371	CcSEcCtD
Fenoldopam—Abdominal pain—Epirubicin—breast cancer	0.000259	0.000371	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Doxorubicin—breast cancer	0.000248	0.000356	CcSEcCtD
Fenoldopam—Abdominal pain—Doxorubicin—breast cancer	0.00024	0.000344	CcSEcCtD
Fenoldopam—Body temperature increased—Doxorubicin—breast cancer	0.00024	0.000344	CcSEcCtD
Fenoldopam—Diarrhoea—Methotrexate—breast cancer	0.000239	0.000344	CcSEcCtD
Fenoldopam—Dizziness—Methotrexate—breast cancer	0.000231	0.000332	CcSEcCtD
Fenoldopam—ADRA2C—endometrium—breast cancer	0.000229	0.0334	CbGeAlD
Fenoldopam—Diarrhoea—Epirubicin—breast cancer	0.000224	0.000321	CcSEcCtD
Fenoldopam—Vomiting—Methotrexate—breast cancer	0.000223	0.000319	CcSEcCtD
Fenoldopam—Headache—Methotrexate—breast cancer	0.000219	0.000315	CcSEcCtD
Fenoldopam—ADRA1A—adipose tissue—breast cancer	0.000217	0.0316	CbGeAlD
Fenoldopam—Dizziness—Epirubicin—breast cancer	0.000217	0.000311	CcSEcCtD
Fenoldopam—DRD2—pituitary gland—breast cancer	0.000213	0.0311	CbGeAlD
Fenoldopam—ADRA2C—uterus—breast cancer	0.000211	0.0307	CbGeAlD
Fenoldopam—Vomiting—Epirubicin—breast cancer	0.000208	0.000299	CcSEcCtD
Fenoldopam—Nausea—Methotrexate—breast cancer	0.000208	0.000298	CcSEcCtD
Fenoldopam—Diarrhoea—Doxorubicin—breast cancer	0.000207	0.000297	CcSEcCtD
Fenoldopam—ADRA2C—pituitary gland—breast cancer	0.000207	0.0302	CbGeAlD
Fenoldopam—ADRA2C—adipose tissue—breast cancer	0.000206	0.0301	CbGeAlD
Fenoldopam—Headache—Epirubicin—breast cancer	0.000205	0.000294	CcSEcCtD
Fenoldopam—Dizziness—Doxorubicin—breast cancer	0.0002	0.000287	CcSEcCtD
Fenoldopam—Nausea—Epirubicin—breast cancer	0.000195	0.000279	CcSEcCtD
Fenoldopam—ADRA1A—adrenal gland—breast cancer	0.000194	0.0283	CbGeAlD
Fenoldopam—Vomiting—Doxorubicin—breast cancer	0.000193	0.000276	CcSEcCtD
Fenoldopam—Headache—Doxorubicin—breast cancer	0.00019	0.000272	CcSEcCtD
Fenoldopam—ADRA2C—adrenal gland—breast cancer	0.000185	0.027	CbGeAlD
Fenoldopam—ADRA2A—endometrium—breast cancer	0.000183	0.0266	CbGeAlD
Fenoldopam—Nausea—Doxorubicin—breast cancer	0.00018	0.000258	CcSEcCtD
Fenoldopam—ADRA2C—female gonad—breast cancer	0.000173	0.0252	CbGeAlD
Fenoldopam—ADRA1A—endocrine gland—breast cancer	0.000169	0.0245	CbGeAlD
Fenoldopam—ADRA2A—uterus—breast cancer	0.000168	0.0245	CbGeAlD
Fenoldopam—ADRA2A—pituitary gland—breast cancer	0.000165	0.0241	CbGeAlD
Fenoldopam—DRD2—endocrine gland—breast cancer	0.000165	0.0241	CbGeAlD
Fenoldopam—ADRA2A—adipose tissue—breast cancer	0.000165	0.024	CbGeAlD
Fenoldopam—ADRA2A—female reproductive system—breast cancer	0.000151	0.0221	CbGeAlD
Fenoldopam—ADRA2A—adrenal gland—breast cancer	0.000148	0.0215	CbGeAlD
Fenoldopam—ADRA2A—female gonad—breast cancer	0.000138	0.0201	CbGeAlD
Fenoldopam—ADRA2A—endocrine gland—breast cancer	0.000128	0.0187	CbGeAlD
Fenoldopam—ADRA2C—lymph node—breast cancer	0.000111	0.0162	CbGeAlD
Fenoldopam—ADRA2A—lymph node—breast cancer	8.86e-05	0.0129	CbGeAlD
Fenoldopam—ADRA2A—Signaling by GPCR—MAPK3—breast cancer	1.49e-05	5.03e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ERBB2—breast cancer	1.48e-05	5.02e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—breast cancer	1.48e-05	5.01e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MDM2—breast cancer	1.48e-05	5.01e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RAF1—breast cancer	1.48e-05	4.99e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDKN1B—breast cancer	1.47e-05	4.97e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RELA—breast cancer	1.47e-05	4.97e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	1.47e-05	4.96e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK8—breast cancer	1.47e-05	4.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MTOR—breast cancer	1.47e-05	4.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CB—breast cancer	1.47e-05	4.95e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—breast cancer	1.46e-05	4.95e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ERBB2—breast cancer	1.46e-05	4.94e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—BRAF—breast cancer	1.46e-05	4.93e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—breast cancer	1.46e-05	4.92e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	1.46e-05	4.92e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	1.45e-05	4.91e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CASP3—breast cancer	1.44e-05	4.87e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CB—breast cancer	1.44e-05	4.87e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MTOR—breast cancer	1.44e-05	4.87e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL2—breast cancer	1.44e-05	4.87e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOS3—breast cancer	1.44e-05	4.87e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—KRAS—breast cancer	1.44e-05	4.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—breast cancer	1.43e-05	4.84e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—breast cancer	1.43e-05	4.83e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CB—breast cancer	1.42e-05	4.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1—breast cancer	1.42e-05	4.8e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT2—breast cancer	1.42e-05	4.8e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EGFR—breast cancer	1.41e-05	4.78e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SRC—breast cancer	1.41e-05	4.77e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—breast cancer	1.41e-05	4.76e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCL8—breast cancer	1.41e-05	4.76e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCND1—breast cancer	1.4e-05	4.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—JUN—breast cancer	1.4e-05	4.73e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HRAS—breast cancer	1.4e-05	4.73e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SRC—breast cancer	1.39e-05	4.7e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CTNNB1—breast cancer	1.39e-05	4.7e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOS3—breast cancer	1.39e-05	4.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCL8—breast cancer	1.39e-05	4.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HRAS—breast cancer	1.38e-05	4.65e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDKN1B—breast cancer	1.37e-05	4.65e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—breast cancer	1.37e-05	4.64e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PIK3CA—breast cancer	1.37e-05	4.63e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MDM2—breast cancer	1.37e-05	4.62e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	1.37e-05	4.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—breast cancer	1.36e-05	4.61e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RAF1—breast cancer	1.36e-05	4.6e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—STAT3—breast cancer	1.36e-05	4.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—breast cancer	1.36e-05	4.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDKN1A—breast cancer	1.36e-05	4.59e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—breast cancer	1.36e-05	4.58e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RELA—breast cancer	1.36e-05	4.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PTEN—breast cancer	1.36e-05	4.58e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	1.35e-05	4.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	1.35e-05	4.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	1.35e-05	4.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CASP3—breast cancer	1.35e-05	4.55e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ERBB2—breast cancer	1.35e-05	4.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL2—breast cancer	1.35e-05	4.55e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—STAT3—breast cancer	1.34e-05	4.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—breast cancer	1.34e-05	4.52e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	1.34e-05	4.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—KRAS—breast cancer	1.34e-05	4.52e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MTOR—breast cancer	1.33e-05	4.49e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CB—breast cancer	1.33e-05	4.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CASP3—breast cancer	1.33e-05	4.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK8—breast cancer	1.33e-05	4.48e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL2—breast cancer	1.32e-05	4.47e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—breast cancer	1.32e-05	4.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	1.32e-05	4.47e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—breast cancer	1.32e-05	4.46e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—breast cancer	1.32e-05	4.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MDM2—breast cancer	1.32e-05	4.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RAF1—breast cancer	1.31e-05	4.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCND1—breast cancer	1.31e-05	4.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—JUN—breast cancer	1.31e-05	4.42e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RELA—breast cancer	1.31e-05	4.41e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK3—breast cancer	1.3e-05	4.39e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CTNNB1—breast cancer	1.3e-05	4.39e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ERBB2—breast cancer	1.3e-05	4.38e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCND1—breast cancer	1.29e-05	4.36e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOS3—breast cancer	1.29e-05	4.36e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—JUN—breast cancer	1.29e-05	4.35e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK3—breast cancer	1.28e-05	4.33e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	1.28e-05	4.33e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MTOR—breast cancer	1.28e-05	4.33e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	1.28e-05	4.32e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCL8—breast cancer	1.28e-05	4.32e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—breast cancer	1.27e-05	4.3e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HRAS—breast cancer	1.27e-05	4.29e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDKN1A—breast cancer	1.27e-05	4.29e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PTEN—breast cancer	1.27e-05	4.28e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—breast cancer	1.26e-05	4.27e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—breast cancer	1.26e-05	4.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SRC—breast cancer	1.26e-05	4.25e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—breast cancer	1.25e-05	4.23e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	1.25e-05	4.22e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDKN1B—breast cancer	1.25e-05	4.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—breast cancer	1.25e-05	4.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PTEN—breast cancer	1.25e-05	4.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—breast cancer	1.24e-05	4.2e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK8—breast cancer	1.24e-05	4.18e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EGFR—breast cancer	1.24e-05	4.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—breast cancer	1.24e-05	4.17e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—breast cancer	1.23e-05	4.17e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCL8—breast cancer	1.23e-05	4.16e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTEN—breast cancer	1.23e-05	4.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	1.23e-05	4.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—breast cancer	1.22e-05	4.14e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.22e-05	4.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HRAS—breast cancer	1.22e-05	4.13e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CASP3—breast cancer	1.22e-05	4.13e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL2—breast cancer	1.22e-05	4.12e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EGFR—breast cancer	1.22e-05	4.12e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK8—breast cancer	1.22e-05	4.12e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.22e-05	4.12e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—breast cancer	1.22e-05	4.11e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—breast cancer	1.21e-05	4.1e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RELA—breast cancer	1.21e-05	4.1e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—STAT3—breast cancer	1.21e-05	4.1e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.21e-05	4.07e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	1.2e-05	4.06e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCND1—breast cancer	1.19e-05	4.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.19e-05	4.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.19e-05	4.02e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	1.19e-05	4.02e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—JUN—breast cancer	1.19e-05	4.01e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.18e-05	3.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.18e-05	3.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL2—breast cancer	1.18e-05	3.97e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SRC—breast cancer	1.17e-05	3.97e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.17e-05	3.95e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KRAS—breast cancer	1.17e-05	3.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.16e-05	3.91e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SRC—breast cancer	1.16e-05	3.9e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—breast cancer	1.16e-05	3.9e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KRAS—breast cancer	1.15e-05	3.89e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.15e-05	3.89e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTEN—breast cancer	1.15e-05	3.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.15e-05	3.87e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—JUN—breast cancer	1.14e-05	3.87e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.14e-05	3.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.14e-05	3.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.14e-05	3.84e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.14e-05	3.84e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.13e-05	3.83e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—breast cancer	1.13e-05	3.81e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.13e-05	3.8e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK8—breast cancer	1.12e-05	3.8e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.12e-05	3.8e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—breast cancer	1.12e-05	3.79e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.12e-05	3.77e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.11e-05	3.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.11e-05	3.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.11e-05	3.75e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.11e-05	3.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.1e-05	3.73e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.1e-05	3.72e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.09e-05	3.7e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL2—breast cancer	1.09e-05	3.69e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.09e-05	3.67e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.08e-05	3.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.08e-05	3.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.08e-05	3.65e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CA—breast cancer	1.07e-05	3.63e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CA—breast cancer	1.07e-05	3.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.07e-05	3.6e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SRC—breast cancer	1.07e-05	3.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.06e-05	3.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—JUN—breast cancer	1.06e-05	3.59e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	1.06e-05	3.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.06e-05	3.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—breast cancer	1.05e-05	3.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.05e-05	3.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.04e-05	3.52e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—breast cancer	1.04e-05	3.51e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—breast cancer	1.04e-05	3.51e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—breast cancer	1.04e-05	3.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.03e-05	3.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.03e-05	3.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.03e-05	3.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.03e-05	3.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.03e-05	3.47e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STAT3—breast cancer	1.03e-05	3.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SRC—breast cancer	1.03e-05	3.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—breast cancer	1.02e-05	3.46e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.01e-05	3.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.01e-05	3.4e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1e-05	3.39e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1e-05	3.38e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HRAS—breast cancer	9.93e-06	3.36e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STAT3—breast cancer	9.9e-06	3.34e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK3—breast cancer	9.82e-06	3.32e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HRAS—breast cancer	9.8e-06	3.31e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KRAS—breast cancer	9.72e-06	3.28e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KRAS—breast cancer	9.57e-06	3.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	9.56e-06	3.23e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—breast cancer	9.55e-06	3.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SRC—breast cancer	9.54e-06	3.22e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—breast cancer	9.52e-06	3.22e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—breast cancer	9.5e-06	3.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK3—breast cancer	9.46e-06	3.19e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—breast cancer	9.38e-06	3.17e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGFR—breast cancer	9.34e-06	3.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—breast cancer	9.29e-06	3.14e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—breast cancer	9.25e-06	3.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—breast cancer	9.2e-06	3.11e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STAT3—breast cancer	9.2e-06	3.11e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—breast cancer	9.18e-06	3.1e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGFR—breast cancer	9e-06	3.04e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	8.93e-06	3.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HRAS—breast cancer	8.85e-06	2.99e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KRAS—breast cancer	8.82e-06	2.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	8.79e-06	2.97e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK3—breast cancer	8.79e-06	2.97e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—breast cancer	8.77e-06	2.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—breast cancer	8.73e-06	2.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CA—breast cancer	8.68e-06	2.93e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—breast cancer	8.65e-06	2.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—breast cancer	8.64e-06	2.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—breast cancer	8.55e-06	2.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—breast cancer	8.52e-06	2.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—breast cancer	8.5e-06	2.87e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KRAS—breast cancer	8.5e-06	2.87e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—breast cancer	8.47e-06	2.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGFR—breast cancer	8.36e-06	2.82e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HRAS—breast cancer	8.26e-06	2.79e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HRAS—breast cancer	8.13e-06	2.75e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CA—breast cancer	8.1e-06	2.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—breast cancer	7.91e-06	2.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KRAS—breast cancer	7.9e-06	2.67e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—breast cancer	7.84e-06	2.65e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—breast cancer	7.81e-06	2.64e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	7.81e-06	2.64e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—breast cancer	7.78e-06	2.63e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—breast cancer	7.55e-06	2.55e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HRAS—breast cancer	7.5e-06	2.53e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—breast cancer	7.3e-06	2.47e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	7.25e-06	2.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HRAS—breast cancer	7.22e-06	2.44e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—breast cancer	7.18e-06	2.43e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—breast cancer	7.18e-06	2.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—breast cancer	7.09e-06	2.39e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—breast cancer	7.02e-06	2.37e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—breast cancer	6.91e-06	2.34e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HRAS—breast cancer	6.71e-06	2.27e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—breast cancer	6.62e-06	2.24e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—breast cancer	6.42e-06	2.17e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—breast cancer	6.38e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—breast cancer	5.93e-06	2e-05	CbGpPWpGaD
